Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STRIBILD in Non-Nucleoside Resistant Patients, An Evaluation of Safety and Efficacy in Vulnerable Population (SINNR STUDY)

NCT02306577 is registered in ClinicalTrials.gov with Vancouver Infectious Diseases Centre as lead sponsor.

NCT NCT02306577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02306577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STRIBILD in Non-Nucleoside Resistant Patients, An Evaluation of Safety and Efficacy in Vulnerable Population (SINNR STUDY)
Lead sponsor
Vancouver Infectious Diseases Centre
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2014
Completion date
July 31, 2016
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, illicit drug user